Courtney DiNardo, MD, MSCE, on Enasidenib Plus Azacitidine in Newly Diagnosed AML

Courtney DiNardo, MD, MSCE, elaborated on interim phase II results regarding enasibenib plus azacitidine in patients with newly diagnosed acute myeloid leukemia, and the results from the QUAZAR trial.

Source: CancerNetwork - January 10, 2020 Category: Cancer & Oncology Authors: Courtney DiNardo, MD, MSCE Source Type: news